HK1071291A1 - User of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies - Google Patents

User of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies

Info

Publication number
HK1071291A1
HK1071291A1 HK05104020A HK05104020A HK1071291A1 HK 1071291 A1 HK1071291 A1 HK 1071291A1 HK 05104020 A HK05104020 A HK 05104020A HK 05104020 A HK05104020 A HK 05104020A HK 1071291 A1 HK1071291 A1 HK 1071291A1
Authority
HK
Hong Kong
Prior art keywords
cure
medicament
prevention
preparation
user
Prior art date
Application number
HK05104020A
Other languages
English (en)
Inventor
Alberto Mantovani
Barbara Bottazi
Giuseppe Peri
Angelo Manfredi
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Publication of HK1071291A1 publication Critical patent/HK1071291A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Zoology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Rheumatology (AREA)
  • Reproductive Health (AREA)
  • Ophthalmology & Optometry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK05104020A 2000-11-03 2005-05-13 User of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies HK1071291A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2000RM000571A IT1317927B1 (it) 2000-11-03 2000-11-03 Uso della pentraxina lunga ptx3 per la preparazione di un medicamentoper il trattamento di patologie autoimmuni.
PCT/IT2001/000530 WO2002036151A2 (en) 2000-11-03 2001-10-18 Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies

Publications (1)

Publication Number Publication Date
HK1071291A1 true HK1071291A1 (en) 2005-07-15

Family

ID=11454977

Family Applications (1)

Application Number Title Priority Date Filing Date
HK05104020A HK1071291A1 (en) 2000-11-03 2005-05-13 User of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies

Country Status (20)

Country Link
US (1) US20040029803A1 (xx)
EP (1) EP1370279B1 (xx)
JP (1) JP4105542B2 (xx)
KR (1) KR100812805B1 (xx)
CN (1) CN1326563C (xx)
AT (1) ATE303819T1 (xx)
AU (2) AU2002215189B2 (xx)
BR (1) BR0115050A (xx)
CA (1) CA2427533A1 (xx)
CZ (1) CZ297242B6 (xx)
DE (1) DE60113304T2 (xx)
DK (1) DK1370279T3 (xx)
ES (1) ES2248401T3 (xx)
HK (1) HK1071291A1 (xx)
HU (1) HUP0401593A2 (xx)
IT (1) IT1317927B1 (xx)
MX (1) MXPA03003805A (xx)
PL (1) PL365291A1 (xx)
SK (1) SK5332003A3 (xx)
WO (1) WO2002036151A2 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1298487B1 (it) * 1997-12-19 2000-01-10 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche comprendenti pentraxina lunga ptx3 per la terapia di patologie di tipo infettivo, infiammatorio o tumorale,
ITRM20020109A1 (it) * 2002-02-28 2003-08-28 Sigma Tau Ind Farmaceuti Derivati funzionali della pentraxina lunga ptx3 per preparare un vaccino autologo per la cura dei tumori.
CA2516335A1 (en) * 2003-02-21 2004-09-02 Medvet Science Pty. Ltd. A method of diagnosis and treatment
ITRM20030595A1 (it) * 2003-12-23 2005-06-24 Sigma Tau Ind Farmaceuti Uso della ptx3 o di un suo derivato funzionale da sola o in associazione con tsg6 per il trattamento di patologie degenarative dell'osso o della cartilagine e per il trattamento della infertilita' femminile.
ITRM20030596A1 (it) * 2003-12-23 2005-06-24 Sigma Tau Ind Farmaceuti Uso di inibitori della pentraxina lunga ptx3, per la preparazione di un medicamento per la prevenzione e cura di patologie che rispondono all'inibizione dell'attivita' biologica di detta ptx3.
ITRM20040489A1 (it) * 2004-10-08 2005-01-08 Sigma Tau Ind Farmaceuti Pentraxina lunga ptx3 deglicosilata o desialidata.
EP1832295A1 (en) * 2006-03-10 2007-09-12 Tecnogen S.P.A. Use of PTX3 for the treatment of viral diseases
US8337828B2 (en) 2006-05-02 2012-12-25 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Use of thymosin alpha 1, alone or in combination with PTX3 or ganciclovir, for the treatment of cytomegalovirus infection
KR101305515B1 (ko) 2011-06-10 2013-09-06 경북대학교 산학협력단 펜트락신 3 단백질의 파킨슨 질환 진단 용도
US20150299277A1 (en) * 2012-06-22 2015-10-22 The University Of Tokyo Agent for treating or preventing systemic inflammatory response syndrome
CN105903001A (zh) * 2016-05-09 2016-08-31 中国科学院海洋研究所 一种鱼类穿透素的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1298487B1 (it) * 1997-12-19 2000-01-10 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche comprendenti pentraxina lunga ptx3 per la terapia di patologie di tipo infettivo, infiammatorio o tumorale,
US6013217A (en) * 1997-12-22 2000-01-11 Dow Corning Corporation Method for extruding thermoplastic resins

Also Published As

Publication number Publication date
SK5332003A3 (en) 2003-12-02
DK1370279T3 (da) 2006-01-23
US20040029803A1 (en) 2004-02-12
ATE303819T1 (de) 2005-09-15
HUP0401593A2 (hu) 2004-12-28
CA2427533A1 (en) 2002-05-10
CZ297242B6 (cs) 2006-10-11
JP2004512372A (ja) 2004-04-22
MXPA03003805A (es) 2004-04-20
EP1370279B1 (en) 2005-09-07
ITRM20000571A1 (it) 2002-05-03
BR0115050A (pt) 2003-09-30
AU1518902A (en) 2002-05-15
CN1561226A (zh) 2005-01-05
CN1326563C (zh) 2007-07-18
JP4105542B2 (ja) 2008-06-25
PL365291A1 (en) 2004-12-27
DE60113304T2 (de) 2006-06-08
DE60113304D1 (de) 2005-10-13
ITRM20000571A0 (it) 2000-11-03
KR20030060918A (ko) 2003-07-16
KR100812805B1 (ko) 2008-03-12
AU2002215189B2 (en) 2006-08-03
IT1317927B1 (it) 2003-07-15
ES2248401T3 (es) 2006-03-16
WO2002036151A3 (en) 2003-10-16
EP1370279A2 (en) 2003-12-17
WO2002036151A2 (en) 2002-05-10
CZ20031043A3 (cs) 2003-09-17

Similar Documents

Publication Publication Date Title
HK1071291A1 (en) User of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies
GB0123381D0 (en) Factor
HUP0203556A2 (hu) Oxkarbazepint tartalmazó gyógyszerkészítmények és alkalmazásuk
HK1042643A1 (en) Body fat measuring instrument.
MXPA02004770A (es) Composiciones terapeuticas y metodos para su uso.
AU2001290229A1 (en) Pyridazinones and triazinones and medicinal use thereof
EP1292279A4 (en) USE OF GLATIRAMER ACETATE (COPOLYMER 1) FOR TREATING DISEASES OF THE CENTRAL NERVOUS SYSTEM
AU7597898A (en) Use of isoflavonoids in the treatment or prevention of postpartum depression
IL131086A0 (en) The use of levobupivacaine in paediatric surgery
ZA200309513B (en) Novel heterocyclic derivatives and medicinal use thereof.
AU7862401A (en) Pharmaceutical compostion comprising trkaig2 for use in the prevention and/or treatment of cancer
AU2918101A (en) Anesthesia instrumentation user interface
AU2001247008A1 (en) Variants of the human amp-activated protein kinase gamma 3 subunit
AP2000001950A0 (en) Paroxetine maleate.
HUP0103262A3 (en) Medicament containing platinum complex compounds and the use thereof
Umland Vladimir Zhirinovskii in Russian politics: three approaches to the emergence of the Liberal-Democratic Party of Russia 1990-1993
MD980129A (en) Antiherpetic remedy
AU2002362383A1 (en) Use of peptides comprising post-translational modifications in the treatment of autoimmune pathologies
PL357906A1 (en) Combination of carboxyalkylethers with antihypertensives and pharmaceutical use
AU2001263287A1 (en) Human protein kinase "13305" and uses therefor
HK1055288A1 (en) Novel aqueous composition and use of the same
AU2001289036A1 (en) Use of human phermone polypeptides
AU2001223910A1 (en) Interferon-alpha use in the treatment of ewing's family of tumors
ZA200103250B (en) The treatment of immunomodulatory related and other diseases or conditions.
GB0021927D0 (en) Use of pharmaceutical combination

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20111018